Skip to main content

NIAAA Staff Profile

 

Focus Area

Biomarkers; Biostatistics; Computational Biology; Data Science; Precision medicine; Systems Biology

Biographical Summary

Dr. Muhammad Arif joined the National Institute of Health as a postdoctoral visiting fellow after completing his doctoral degree in Systems Biology at KTH Royal Institute of Technology (Stockholm, Sweden) in 2021. He is jointly appointed by two labs, Section on Fibrotic Disorders and Laboratory of Cardiovascular Physiology and Tissue Injury, at the National Institute of Alcohol Abuse and Alcoholism. As a systems biology expert, Dr. Arif develops and employs machine learning and biological network analysis approaches to discover molecular mechanisms and novel therapeutic targets for many systemic and progressive diseases, including pulmonary fibrosis, and cardiometabolic diseases.

Selected Publications

Full publication list: Google Scholar

An Integrative Multiomics Framework for Identification of Therapeutic Targets in Pulmonary Fibrosis
PMID: 37038090
Advanced Science
M Arif*, A Basu*, K Wolf, J Park, L Pommerolle, M Behee, B Gochuico, R Cinar

Data-driven transcriptomics analysis identifies PCSK9 as a novel key regulator in liver aging
PMID: 37726433
GeroScience
M Arif*, C Matyas*, P Mukhopadhyay, B Yokus, E Trojnar, J Paloczi, B Paes-Leme, S Zhao, F Lohoff, G Haskó, P Pacher

Chronic Alcohol Intake Compromises Lung Immunity by Altering Immunometabolism in Humans and Mouse Models
PMID: 39024537
American Journal of Respiratory Cell and Molecular Biology
L Pommerolle*, M Arif*, M Behee, C Appolonia, A Basu, K Wolf, CN Zawatsky, N Johnson, O Rivellini, J Park, Resat Cinar

Looking for U.S. government information and services?
Visit USA.gov